This event is archived. Final snapshot from when the story concluded. View on Dashboard
Business board expansion

ZEO ScientifiX expands Medical Advisory Board

Analysis based on 6 articles · First reported Jun 09, 2026 · Last updated Jun 09, 2026

Sentiment
40
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The expansion of ZEO ScientifiX's Medical Advisory Board is likely to be viewed positively by the market, as it strengthens the company's scientific credibility and leadership in the growing field of regenerative medicine. This could lead to increased investor confidence and potentially a positive impact on ZEO ScientifiX's stock price.

biotechnology healthcare

ZEO ScientifiX, a biologics research and products company, announced the expansion of its Medical Advisory Board with the addition of nine highly-recognized physicians and scientific innovators. These new members bring expertise across various disciplines including orthopedics, oncology, longevity science, pain management, plastic surgery, and advanced biologic therapies. The expanded board aims to deepen ZEO ScientifiX's scientific foundation, advance clinical innovation, and enhance physician education in regenerative medicine. Key new members include Elizabeth Parrish, a pioneer in gene-based longevity biotechnology, and Mark A. Rosenberg, president of Advanced Medical Therapeutics. George C. Shapiro, ZEO ScientifiX's Chief Medical Officer, chairs the board, emphasizing the company's commitment to understanding and influencing biological systems related to aging.

priv
ZEO ScientifiX expanded its Medical Advisory Board with nine new members, strengthening its scientific leadership in regenerative and longevity medicine. This expansion aims to advance clinical innovation and physician education, potentially enhancing the company's reputation and market position.
Importance 100.0 Sentiment 40.0
per
George C. Shapiro, ZEO ScientifiX's Chief Medical Officer, serves as Chairman of the Medical Advisory Board. He emphasized the long-term goal of understanding and influencing biological systems that drive aging.
Importance 70.0 Sentiment 20.0
per
Mark A. Rosenberg joined the Medical Advisory Board of ZEO ScientifiX, bringing his experience as president and medical director of Advanced Medical Therapeutics and Integrative Cancer Therapeutics. He expressed excitement about pioneering the next generation of regenerative medicine.
Importance 60.0 Sentiment 20.0
per
Neel Amin joined the Medical Advisory Board of ZEO ScientifiX, specializing in interventional pain medicine. He highlighted the potential of biologic therapies to change how chronic pain and degenerative conditions are treated.
Importance 60.0 Sentiment 20.0
per
Andrea Asseff-Llanes joined the Medical Advisory Board of ZEO ScientifiX, contributing her expertise in regenerative dental medicine.
Importance 50.0 Sentiment 20.0
per
Elizabeth Parrish joined the Medical Advisory Board of ZEO ScientifiX, bringing her pioneering work in gene-based longevity biotechnology.
Importance 50.0 Sentiment 20.0
per
Faryal Farooqi joined the Medical Advisory Board of ZEO ScientifiX, specializing in longevity medicine and metabolic health.
Importance 50.0 Sentiment 20.0
per
Michael Swartzon joined the Medical Advisory Board of ZEO ScientifiX, contributing his expertise as an orthopedic sports medicine physician.
Importance 50.0 Sentiment 20.0
per
David Karli joined the Medical Advisory Board of ZEO ScientifiX, contributing his expertise as an orthopedic surgeon and regenerative medicine researcher.
Importance 50.0 Sentiment 20.0
per
Jacob Sanchez joined the Medical Advisory Board of ZEO ScientifiX, specializing in aesthetic medicine and provider education.
Importance 50.0 Sentiment 20.0
per
Constantino Mendieta joined the Medical Advisory Board of ZEO ScientifiX, known for innovations in regenerative surgical approaches.
Importance 50.0 Sentiment 20.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.